股本结构
单位：万股
| 公告日期 | 2024-04-25 | 2024-04-25 | 2024-03-15 | 2024-03-15 | 2023-11-14 | 2023-11-14 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6430.66 | 6429.87 | 6421.72 | 6360.10 | 6359.72 | 5959.72 |
| 普通股本 | 6430.66 | 6429.87 | 6421.72 | 6360.10 | 6359.72 | 5959.72 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-09 | 2024-03-31 | 2024-03-07 | 2023-12-31 | 2023-10-31 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-25 | 6430.66 | 未披露 | 定期报告 | 2024-04-09 |
| 2024-04-25 | 6429.87 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-03-15 | 6421.72 | 未披露 | 定期报告 | 2024-03-07 |
| 2024-03-15 | 6360.10 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of shares in connection with asset acquisitions
Share-based compensation activity
Issuance of shares in connection with private placements, net of issuance costs of $6,418
|
2023-12-31 |
| 2023-11-14 | 6359.72 | 未披露 | 定期报告 | 2023-10-31 |
| 2023-11-14 | 5959.72 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Share based compensation activity
|
2023-09-30 |
| 2023-08-10 | 5953.53 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of shares in connection with PIPE, net of issuance costs
Share-based compensation activity
Issuance of shares in connection with asset acquisition
|
2023-06-30 |
| 2023-05-11 | 5950.03 | 未披露 | 定期报告 | 2023-05-08 |
| 2023-04-27 | 4872.64 | 未披露 | 定期报告 | 2023-04-12 |
| 2023-03-14 | 4866.63 | 未披露 | 定期报告 | 2023-03-08 |
| 2022-12-23 | 4847.72 | 未披露 | 定期报告 | 2022-11-30 |
| 2022-11-10 | 4472.57 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Share based compensation activity
|
2022-09-30 |
| 2022-05-02 | 4471.07 | 未披露 | 定期报告 | 2022-04-30 |
| 2022-05-02 | 4469.07 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-05-12 | 4471.07 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Share based compensation activity
|
2022-03-31 |
| 2022-03-10 | 4467.76 | 未披露 | 定期报告 | 2022-03-08 |
| 2022-03-10 | 4454.89 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of shares in connection with equity method and other investments
Issuance of shares in connection with asset acquisitions
Exercise of share options
|
2021-12-31 |
| 2021-11-10 | 4444.86 | 未披露 | 定期报告 | 2021-11-01 |
| 2021-11-10 | 4431.64 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of share options
|
2021-09-30 |
| 2021-08-11 | 4431.49 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-11 | 4430.95 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of share options
|
2021-06-30 |
| 2021-05-11 | 4428.21 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Exercise of share options
Issuance of shares in connection with equity method and other investments
|
2021-03-31 |
| 2021-03-11 | 4426.42 | 未披露 | 定期报告 | 2021-03-08 |
| 2021-03-11 | 4418.92 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of shares in connection with asset acquisition
Issuance of shares in at-the-market offering, net of issuance costs of $505,650
Issuance of shares in connection with public placement, net of issuance costs of $4,635,362
Exercise of share options
|
2020-12-31 |
| 2020-11-23 | 4341.22 | 未披露 |
更多>>
1.Ordinary shares offered by the company 5,000,000 ordinary shares.
2.The number of ordinary shares outstanding reflected in the discussion and table above is based on 38,412,163 ordinary shares outstanding as of September 30, 2020.
|
2020-11-23 |
| 2020-11-05 | 3841.22 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of shares in at-the-market offering, net of issuance costs of $505,650
Exercise of share options
|
2020-09-30 |
| 2020-08-06 | 3736.29 | 未披露 | 定期报告 | 2020-07-31 |
| 2020-05-07 | 3736.24 | 未披露 | 定期报告 | 2020-04-30 |
| 2020-04-21 | 3684.04 | 未披露 | 定期报告 | 2020-04-06 |
| 2020-05-07 | 3681.79 | 未披露 |
更多>>
From December 31, 2019 to March 8, 2020
Exercise of share options
|
2020-03-08 |
| 2020-03-11 | 3679.19 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of ordinary shares in connection with a license agreement
Sale of ordinary shares in connection with public and private placements, net of issuance costs of $7,497,852
Issuance of ordinary shares in connection with payables
Exercise of share options
Share-based compensation
|
2019-12-31 |
| 2019-11-07 | 3657.17 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Sale of ordinary shares in connection with public offering, net of issuance costs of $5,042,795
Issuance of ordinary shares in connection with payables
Exercise of share options
|
2019-09-30 |
| 2019-08-12 | 3654.28 | 未披露 | 定期报告 | 2019-08-12 |
| 2019-08-07 | 3336.93 | 未披露 | 定期报告 | 2019-07-31 |
| 2019-07-17 | 3334.72 | 未披露 | 定期报告 | 2019-07-12 |
| 2019-08-07 | 3334.28 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Exercise of share options
|
2019-06-30 |
| 2019-05-14 | 3334.26 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of convertible preferred C shares in connection with a license agreement
Sale of ordinary shares in connection with private placement, net of issuance costs of $ 2,426,953
|
2019-03-31 |
| 2019-03-26 | 3318.37 | 未披露 | 定期报告 | 2019-03-15 |
| 2019-03-26 | 2738.66 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of convertible preferred C shares in connection with a license agreement
Sale of convertible preferred C shares, net of issuance costs
Exercise of warrants
Conversion of convertible preferred C shares into A ordinary shares
Sale of ordinary shares in initial public offering, net of issuance costs of $9,807,622
Issuance of ordinary shares in connection with Vector Neurosciences acquisition
Share-based compensation
|
2018-12-31 |
| 2018-11-08 | 2738.66 | 未披露 | 定期报告 | 2018-10-31 |
| 2018-08-08 | 2718.41 | 未披露 |
更多>>
from December 31, 2017 to June 30, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of preferred C shares in connection with a license agreement
Issuance of convertible preferred C shares, net of issuance costs
Share-based compensation
Exercise of warrants
Conversion of convertible preferred C shares into A ordinary shares
Sale of A ordinary shares in initial public offering, net of issuance costs of $9,541,530
|
2018-06-30 |
| 2018-06-08 | 2718.41 | 未披露 |
更多>>
1.Ordinary shares offered 5,000,000 ordinary shares.
2.The number of our ordinary shares to be outstanding after this offering is based on 9,376,352 ordinary shares outstanding as of April 30, 2018
3.a 1 for 3.881 reverse share split of all outstanding ordinary shares and preferred shares (by way of consolidation of the share capital of the Company)
|
2018-06-08 |
| 2018-05-29 | 937.64 | 未披露 |
更多>>
a 1 for 3.881 reverse share split of all outstanding ordinary shares
|
2018-04-30 |
| 2018-05-14 | 3623.51 | 3633.07 |
更多>>
From December 31, 2017 To March 31, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of preferred C shares in connection with a license agreement
Issuance of convertible preferred C shares, net of issuance costs
Share-based compensation
|
2018-03-31 |
From December 31, 2022 to December 31, 2023
Issuance of shares in connection with asset acquisitions
Share-based compensation activity
Issuance of shares in connection with private placements, net of issuance costs of $6,418
From June 30, 2023 to September 30, 2023
Share based compensation activity
From March 31, 2023 to June 30, 2023
Issuance of shares in connection with PIPE, net of issuance costs
Share-based compensation activity
Issuance of shares in connection with asset acquisition
From June 30, 2022 to September 30, 2022
Share based compensation activity
From December 31, 2021 to March 31, 2022
Share based compensation activity
From December 31, 2020 to December 31, 2021
Issuance of shares in connection with equity method and other investments
Issuance of shares in connection with asset acquisitions
Exercise of share options
From June 30, 2021 to September 30, 2021
Exercise of share options
From March 31, 2021 to June 30, 2021
Exercise of share options
From December 31, 2020 To March 31, 2021
Exercise of share options
Issuance of shares in connection with equity method and other investments
from December 31, 2019 to December 31, 2020
Issuance of shares in connection with asset acquisition
Issuance of shares in at-the-market offering, net of issuance costs of $505,650
Issuance of shares in connection with public placement, net of issuance costs of $4,635,362
Exercise of share options
1.Ordinary shares offered by the company 5,000,000 ordinary shares.
2.The number of ordinary shares outstanding reflected in the discussion and table above is based on 38,412,163 ordinary shares outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020
Issuance of shares in at-the-market offering, net of issuance costs of $505,650
Exercise of share options
From December 31, 2019 to March 8, 2020
Exercise of share options
from December 31, 2018 to December 31, 2019
Issuance of ordinary shares in connection with a license agreement
Sale of ordinary shares in connection with public and private placements, net of issuance costs of $7,497,852
Issuance of ordinary shares in connection with payables
Exercise of share options
Share-based compensation
from June 30, 2019 to September 30, 2019
Sale of ordinary shares in connection with public offering, net of issuance costs of $5,042,795
Issuance of ordinary shares in connection with payables
Exercise of share options
from March 31, 2019 to June 30,2019
Exercise of share options
from December 31, 2018 to March 31, 2019
Issuance of convertible preferred C shares in connection with a license agreement
Sale of ordinary shares in connection with private placement, net of issuance costs of $ 2,426,953
from December 31, 2017 to December 31, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of convertible preferred C shares in connection with a license agreement
Sale of convertible preferred C shares, net of issuance costs
Exercise of warrants
Conversion of convertible preferred C shares into A ordinary shares
Sale of ordinary shares in initial public offering, net of issuance costs of $9,807,622
Issuance of ordinary shares in connection with Vector Neurosciences acquisition
Share-based compensation
from December 31, 2017 to June 30, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of preferred C shares in connection with a license agreement
Issuance of convertible preferred C shares, net of issuance costs
Share-based compensation
Exercise of warrants
Conversion of convertible preferred C shares into A ordinary shares
Sale of A ordinary shares in initial public offering, net of issuance costs of $9,541,530
1.Ordinary shares offered 5,000,000 ordinary shares.
2.The number of our ordinary shares to be outstanding after this offering is based on 9,376,352 ordinary shares outstanding as of April 30, 2018
3.a 1 for 3.881 reverse share split of all outstanding ordinary shares and preferred shares (by way of consolidation of the share capital of the Company)
a 1 for 3.881 reverse share split of all outstanding ordinary shares
From December 31, 2017 To March 31, 2018
Issuance of convertible preferred C shares in connection with payables
Issuance of preferred C shares in connection with a license agreement
Issuance of convertible preferred C shares, net of issuance costs
Share-based compensation